Analysts expect Novavax Inc to report revenue of 70.09 M for Q3 26, against a range of 63.18 M to 77.01 M. The most recent reported quarter, Q2 26, came in at 56.70 M, a 11.7% beat against the 50.75 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 84.51 M | 88.31 M | 666.65 M | 239.24 M | 70.44 M | 147.14 M | 139.51 M | 56.70 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 85.60 M | 81.54 M | 348.47 M | 172.79 M | 44.19 M | 98.76 M | 83.97 M | 53.91 M | 77.01 M | 99.12 M | 14.55 M | 19.49 M | 272.34 M | 121.34 M | 65.15 M | 21.02 M | ||||||||||
| Low Estimate | 70.61 M | 76.22 M | 317.73 M | 144.37 M | 38.19 M | 86.83 M | 72.40 M | 47.59 M | 63.18 M | 93.34 M | 12.97 M | 17.68 M | 227.18 M | 109.44 M | 57.64 M | 18.57 M | ||||||||||
| Consensus Estimate | 78.10 M | 78.88 M | 333.10 M | 158.58 M | 41.19 M | 92.80 M | 78.19 M | 50.75 M | 70.09 M | 96.23 M | 13.76 M | 18.59 M | 249.76 M | 115.39 M | 61.40 M | 19.80 M |
Analysts expect Novavax Inc to report earnings per share of -0.22 for Q3 26, against a range of -0.24 to -0.20. The most recent reported quarter, Q2 26, came in at -0.32, a 17.9% beat against the -0.39 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.76 | -0.51 | 2.93 | 0.62 | -1.25 | 0.11 | -0.06 | -0.32 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.73 | -0.49 | -0.42 | 0.01 | -1.05 | -0.44 | -0.24 | -0.35 | -0.20 | -0.09 | -0.28 | -0.20 | 0.45 | 0.08 | 0.10 | -0.38 | ||||||||||
| Low Estimate | -0.89 | -0.55 | -0.46 | 0.01 | -1.23 | -0.48 | -0.26 | -0.43 | -0.24 | -0.11 | -0.32 | -0.24 | 0.37 | 0.08 | 0.08 | -0.44 | ||||||||||
| Consensus Estimate | -0.81 | -0.52 | -0.44 | 0.01 | -1.14 | -0.46 | -0.25 | -0.39 | -0.22 | -0.10 | -0.30 | -0.22 | 0.41 | 0.08 | 0.09 | -0.41 |
Pull Wall Street consensus for Novavax Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=NVAX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "NVAX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=NVAX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();